2.02
-0.07(-3.35%)
Currency In USD
| Previous Close | 2.09 |
| Open | 2.08 |
| Day High | 2.11 |
| Day Low | 2.02 |
| 52-Week High | 4.8 |
| 52-Week Low | 2.01 |
| Volume | 4.19M |
| Average Volume | 5.3M |
| Market Cap | 1.04B |
| PE | -18.36 |
| EPS | -0.11 |
| Moving Average 50 Days | 2.46 |
| Moving Average 200 Days | 2.81 |
| Change | -0.07 |
If you invested $1000 in Clover Health Investments, Corp. (CLOV) since IPO date, it would be worth $198.04 as of February 21, 2026 at a share price of $2.02. Whereas If you bought $1000 worth of Clover Health Investments, Corp. (CLOV) shares 5 years ago, it would be worth $182.31 as of February 21, 2026 at a share price of $2.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
GlobeNewswire Inc.
Feb 17, 2026 9:05 PM GMT
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Glob
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Jan 29, 2026 9:05 PM GMT
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Thursday, Februa
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
GlobeNewswire Inc.
Jan 14, 2026 1:30 PM GMT
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort ec